Nyumbani › Limfoma ya Folikuli › Ohio › Columbus
Majaribio ya kliniki ya Limfoma ya Folikuli katika Columbus, OH
Masomo 13 ya Limfoma ya Folikuli yanatafuta washiriki katika vituo vya Columbus na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
InaajiriHatua 3
- Ohio State University Comprehensive Cancer Center, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
InaajiriHatua 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
InaajiriHatua 1
- The Ohio State University (OSU), Columbus
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
InaajiriHatua 3
- Research Site, Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
InaajiriHatua 2
- Research Site, Columbus
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
InaajiriUtafiti wa uchunguzi
- OhioHealth Research Institute, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
InaajiriHatua 1
- Ohio State University Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
InaajiriHatua 1/2
- The Ohio State University Wexner Medical Center, Columbus
Epcoritamab and Rituximab for First-line Follicular Lymphoma
InaajiriHatua 2
- The Ohio State University Wexner Medical Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
InaajiriHatua 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
InaajiriHatua 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
InaajiriUtafiti wa uchunguzi
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
InaajiriHatua 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Majaribio ya Limfoma ya Folikuli katika miji mingine
- New York City, NYUtafiti 24
- Milwaukee, WIUtafiti 19
- Nashville, TNUtafiti 18
- Houston, TXUtafiti 18
- Boston, MAUtafiti 17
- Baldwin Park, CAUtafiti 16
- Seattle, WAUtafiti 15
- Durham, NCUtafiti 15
- Salt Lake City, UTUtafiti 13
- Chicago, ILUtafiti 12
- Philadelphia, PAUtafiti 12
- San Antonio, TXUtafiti 12
Masomo mengine katika Columbus
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 56
- Saratani ya MatitiUtafiti 39
- Kansari ya MayaiUtafiti 39
- Saratani (aina zote)Utafiti 38
- Saratan ya MapafuUtafiti 37
- Leukemia ya Myeloid ya GhaflaUtafiti 35
- Leukemia ya Limfosaiti ya Muda MrefuUtafiti 28
- Saratani ya MetastasiUtafiti 27
- Saratani ya EndometrialUtafiti 25
- Kansari ya kolorektaliUtafiti 24
- Saratani ya ProstateUtafiti 24
- Multiple MyelomaUtafiti 24
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.